Pain/Inflammation Featured Articles

  1. Engage With Patients, Not Paper 4/12/2013

    Technology has come a long way, and continues to evolve in ways that many of us could not have imagined 20 years ago. Consider the iPhone 5. This device has a user friendly interface, PassPort (an app that keeps all your gift cards, coupons, boarding passes, and tickets organized, and which are ready for you when you need them), enables cloud computing, and of course has Siri, which remembers where you are, reminds you of appointments, and gives you directions. Just 10 years ago, I could not have imagined doing all of that from the palm of my hand.

     

    Michael Smyth, general manager of TransPerfect Life Sciences Solutions, thinks of this technology every time he walks into a clinical investigative site and sees row after row of shelves piled high with binders full of paper. “When a new technology comes out, like the iPhone 5, most people can’t wait to embrace it,” he says.  “It makes our lives better and easier in so many ways, it is almost counter-productive to NOT embrace it. I know many people in the life science industry who have this device. Yet when it comes to documenting the results of clinical trials, many sites continue to use the same methods that were used 100 years ago, even though far more efficient and time-saving technologies are now available. I believe it is time for the life sciences industry to embrace these technologies as well.”

  2. Pharma Merger Trends - Insights From An Industry Consultant At Rondaxe 3/26/2013

    Just three months into 2013, several merger announcements have already crossed the wires. I spoke with Joel Lirot, VP of business development for consulting firm Rondaxe, about merger and acquisition trends he sees in the pharmaceutical industry.

  3. Former Acorda Chief Medical Officer Discusses Benefits And Pitfalls Of Outsourcing 3/18/2013

    Dr. Thomas C. Wessel, former chief medical officer for Acorda Therapeutics, recently shares his expertise acquired from working with the clinical development and operations, regulatory affairs, biostatistics, data management and drug safety functions.

  4. Make Your CRO An Extension Of Your Internal Team 3/4/2013

    The healthcare contract research outsourcing market is expected to grow from $25.1 billion in 2011 to $65 billion by 2018. Eight industry experts discuss how to turn your CRO into a strategic partner.

  5. Online Patient Communities: Accelerating Clinical Trials And Improving Patient Outcomes 3/1/2013

    As patients take an increasingly active role in managing their own healthcare, online communities increase the possibility of physician-less clinical trials.

  6. Is Innovation In Chromatography Losing Steam? 1/31/2013

    BIO innovation notes - Both end users and vendors are investing less.

  7. The Rx For Dx Leadership At Roche 10/31/2012

    Dr. James Creeden, chief medical officer of Roche Professional Diagnostics, shares the strategizing and decision making inside RPD, as well as, the outside world with its competitive landscape and drug-diagnostic combinations.

  8. Genzyme: Helping Sanofi Break Free Of Blockbuster Medicines 10/28/2012

    Sanofi’s 2009 annual report indicated that the company needed to transition away from a reliance on blockbuster medicines, instead, optimize its approach to R&D, which is something Genzyme could help with.

  9. Ten Things You Need To Know About Conducting A Human Abuse Liability Study 10/10/2012

    Tips about the HAL Study from Dr. Lynn Webster, medical director of CRI Lifetree and president-elect of the American Academy of Pain Medicine.

  10. Can Rapid Mobile Diagnostics Speed Up Clinical Trials And Regulatory Reviews? 8/30/2012

    As a new technological space containing all the alternatives, the most practical and immediate application for Rapid Mobile Diagnostics (RMDx) may be in clinical trials.